<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2018-01-31" version="157">
<accession>O00757</accession>
<accession>Q17R39</accession>
<accession>Q6FI53</accession>
<name>F16P2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Fructose-1,6-bisphosphatase isozyme 2</fullName>
<shortName>FBPase 2</shortName>
<ecNumber>3.1.3.11</ecNumber>
</recommendedName>
<alternativeName>
<fullName>D-fructose-1,6-bisphosphate 1-phosphohydrolase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Muscle FBPase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FBP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Gene" volume="212" first="295" last="304">
<title>Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase.</title>
<authorList>
<person name="Tillman H."/>
<person name="Eschrich K."/>
</authorList>
<dbReference type="PubMed" id="9678974"/>
<dbReference type="DOI" id="10.1016/S0378-1119(98)00181-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT LEU-86</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Halleck A."/>
<person name="Ebert L."/>
<person name="Mkoundinya M."/>
<person name="Schick M."/>
<person name="Eisenstein S."/>
<person name="Neubert P."/>
<person name="Kstrang K."/>
<person name="Schatten R."/>
<person name="Shen B."/>
<person name="Henze S."/>
<person name="Mar W."/>
<person name="Korn B."/>
<person name="Zuo D."/>
<person name="Hu Y."/>
<person name="LaBaer J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LEU-86</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Histol. Histopathol." volume="18" first="135" last="142">
<title>Immunohistochemical localization of human fructose-1,6-bisphosphatase in subcellular structures of myocytes.</title>
<authorList>
<person name="Gizak A."/>
<person name="Rakus D."/>
<person name="Dzugaj A."/>
</authorList>
<dbReference type="PubMed" id="12507293"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="5577" last="5581">
<title>The origin of the high sensitivity of muscle fructose 1,6-bisphosphatase towards AMP.</title>
<authorList>
<person name="Rakus D."/>
<person name="Maciaszczyk E."/>
<person name="Wawrzycka D."/>
<person name="Ulaszewski S."/>
<person name="Eschrich K."/>
<person name="Dzugaj A."/>
</authorList>
<dbReference type="PubMed" id="16213487"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.09.021"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>COFACTOR</scope>
<scope>MUTAGENESIS OF LYS-21; THR-178 AND GLN-180</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="1347" last="1350">
<title>Glu 69 is essential for the high sensitivity of muscle fructose-1,6-bisphosphatase inhibition by calcium ions.</title>
<authorList>
<person name="Zarzycki M."/>
<person name="Maciaszczyk E."/>
<person name="Dzugaj A."/>
</authorList>
<dbReference type="PubMed" id="17350621"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.02.051"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF GLU-70</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Proteins" volume="72" first="209" last="216">
<title>Evolutionary conserved N-terminal region of human muscle fructose 1,6-bisphosphatase regulates its activity and the interaction with aldolase.</title>
<authorList>
<person name="Gizak A."/>
<person name="Maciaszczyk E."/>
<person name="Dzugaj A."/>
<person name="Eschrich K."/>
<person name="Rakus D."/>
</authorList>
<dbReference type="PubMed" id="18214967"/>
<dbReference type="DOI" id="10.1002/prot.21909"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH ALDOA</scope>
<scope>MUTAGENESIS OF 1-MET--ASP-10</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Proteins" volume="77" first="262" last="267">
<title>Muscle FBPase is targeted to nucleus by its 203KKKGK207 sequence.</title>
<authorList>
<person name="Gizak A."/>
<person name="Maciaszczyk-Dziubinska E."/>
<person name="Jurowicz M."/>
<person name="Rakus D."/>
</authorList>
<dbReference type="PubMed" id="19626708"/>
<dbReference type="DOI" id="10.1002/prot.22506"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>MUTAGENESIS OF 204-LYS--LYS-208</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Acta Crystallogr. D" volume="67" first="1028" last="1034">
<title>Structure of E69Q mutant of human muscle fructose-1,6-bisphosphatase.</title>
<authorList>
<person name="Zarzycki M."/>
<person name="Kolodziejczyk R."/>
<person name="Maciaszczyk-Dziubinska E."/>
<person name="Wysocki R."/>
<person name="Jaskolski M."/>
<person name="Dzugaj A."/>
</authorList>
<dbReference type="PubMed" id="22120740"/>
<dbReference type="DOI" id="10.1107/S090744491104385X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 2-339 OF MUTANT GLN-70 IN COMPLEX WITH FRUCTOSE-6-PHOSPHATE AND AMP</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E71242" last="E71242">
<title>Crystal structures of human muscle fructose-1,6-bisphosphatase: novel quaternary states, enhanced AMP affinity, and allosteric signal transmission pathway.</title>
<authorList>
<person name="Shi R."/>
<person name="Chen Z.Y."/>
<person name="Zhu D.W."/>
<person name="Li C."/>
<person name="Shan Y."/>
<person name="Xu G."/>
<person name="Lin S.X."/>
</authorList>
<dbReference type="PubMed" id="24086250"/>
<dbReference type="DOI" id="10.1371/journal.pone.0071242"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 2-339 OF WILD-TYPE AND MUTANT ARG-33 IN COMPLEXES WITH FRUCTOSE-6-PHOSPHATE; PHOSPHATE ION; AMP; ZINC ION AND MAGNESIUM IONS</scope>
<scope>COFACTOR</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="10 11">Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations and probably participates in glycogen synthesis from carbohydrate precursors, such as lactate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10 11">D-fructose 1,6-bisphosphate + H(2)O = D-fructose 6-phosphate + phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="9 14">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<text evidence="9 14">Binds 3 Mg(2+) ions per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="9 10 11">Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as allosteric inhibitor. Fructose 2,6-bisphosphate acts as competitive inhibitor. Strongly inhibited by Ca(2+).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="9 10">1.3 uM for fructose 1,6-bisphosphate</KM>
<KM evidence="9 10">2.6 uM for fructose 1,6-bisphosphate</KM>
<text>The kinetic constants are determined for the recombinant enzyme expressed in E.coli.</text>
</kinetics>
</comment>
<comment type="pathway">
<text>Carbohydrate biosynthesis; gluconeogenesis.</text>
</comment>
<comment type="subunit">
<text evidence="11 13 14">Homotetramer. Interacts with ALDOA; the interaction blocks inhibition by physiological concentrations of AMP and reduces inhibition by Ca(2+). Interacts with alpha-actinin and F-actin.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719781"/>
<interactant intactId="EBI-719781"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-719781"/>
<interactant intactId="EBI-712740">
<id>P09467</id>
<label>FBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>myofibril</location>
<location>sarcomere</location>
<location>Z line</location>
</subcellularLocation>
<text evidence="5">In neonatal cardiomyocytes, distributed throughout the cytosol, accumulating in the intercalated disks which occur at the Z line of cardiomyocytes and connect adjacent cells, and also located in the nucleus; dissociates from the Z line following an increase in cytosolic Ca(2+) concentration (By similarity). In muscle precursor cells, localizes predominantly to the nucleus and to a lesser extent to the cytoplasm at the proliferative phase, while mainly localizing to the cytoplasm at the differentiation phase (By similarity). Colocalizes with ALDOA and alpha-actinin on both sides of the Z line of skeletal muscle; dissociates rapidly from the Z line following an increase in cytosolic Ca(2+) concentration.</text>
</comment>
<comment type="tissue specificity">
<text evidence="7">Expressed in skeletal muscle (at protein level).</text>
</comment>
<comment type="miscellaneous">
<text evidence="17 18">Specific for the alpha-anomer of the substrate (PubMed:22120740). The Arg-33 mutant form has been shown to act on the beta-anomer (PubMed:24086250).</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the FBPase class 1 family.</text>
</comment>
<dbReference type="EC" id="3.1.3.11"/>
<dbReference type="EMBL" id="Y10812">
<property type="protein sequence ID" value="CAA71772.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR536483">
<property type="protein sequence ID" value="CAG38722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161728">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113632">
<property type="protein sequence ID" value="AAI13633.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117477">
<property type="protein sequence ID" value="AAI17478.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6711.1"/>
<dbReference type="RefSeq" id="NP_003828.2">
<property type="nucleotide sequence ID" value="NM_003837.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.61255"/>
<dbReference type="PDB" id="3IFA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A/B/C/D=2-339"/>
</dbReference>
<dbReference type="PDB" id="3IFC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B/C/D=2-339"/>
</dbReference>
<dbReference type="PDB" id="4HE0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="4HE1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="4HE2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5ET5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.67"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5ET6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.84"/>
<property type="chains" value="A/B/C/D=2-339"/>
</dbReference>
<dbReference type="PDB" id="5ET7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B/C/D=2-339"/>
</dbReference>
<dbReference type="PDB" id="5ET8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5K54">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5K55">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5K56">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDB" id="5L0A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=2-339"/>
</dbReference>
<dbReference type="PDBsum" id="3IFA"/>
<dbReference type="PDBsum" id="3IFC"/>
<dbReference type="PDBsum" id="4HE0"/>
<dbReference type="PDBsum" id="4HE1"/>
<dbReference type="PDBsum" id="4HE2"/>
<dbReference type="PDBsum" id="5ET5"/>
<dbReference type="PDBsum" id="5ET6"/>
<dbReference type="PDBsum" id="5ET7"/>
<dbReference type="PDBsum" id="5ET8"/>
<dbReference type="PDBsum" id="5K54"/>
<dbReference type="PDBsum" id="5K55"/>
<dbReference type="PDBsum" id="5K56"/>
<dbReference type="PDBsum" id="5L0A"/>
<dbReference type="ProteinModelPortal" id="O00757"/>
<dbReference type="SMR" id="O00757"/>
<dbReference type="BioGrid" id="114317">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="O00757">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="MINT" id="MINT-1374932"/>
<dbReference type="STRING" id="9606.ENSP00000364486"/>
<dbReference type="DEPOD" id="O00757"/>
<dbReference type="iPTMnet" id="O00757"/>
<dbReference type="PhosphoSitePlus" id="O00757"/>
<dbReference type="SwissPalm" id="O00757"/>
<dbReference type="BioMuta" id="FBP2"/>
<dbReference type="EPD" id="O00757"/>
<dbReference type="MaxQB" id="O00757"/>
<dbReference type="PaxDb" id="O00757"/>
<dbReference type="PeptideAtlas" id="O00757"/>
<dbReference type="PRIDE" id="O00757"/>
<dbReference type="DNASU" id="8789"/>
<dbReference type="Ensembl" id="ENST00000375337">
<property type="protein sequence ID" value="ENSP00000364486"/>
<property type="gene ID" value="ENSG00000130957"/>
</dbReference>
<dbReference type="GeneID" id="8789"/>
<dbReference type="KEGG" id="hsa:8789"/>
<dbReference type="UCSC" id="uc004auv.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8789"/>
<dbReference type="DisGeNET" id="8789"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130957.4"/>
<dbReference type="GeneCards" id="FBP2"/>
<dbReference type="HGNC" id="HGNC:3607">
<property type="gene designation" value="FBP2"/>
</dbReference>
<dbReference type="HPA" id="HPA012513"/>
<dbReference type="HPA" id="HPA055286"/>
<dbReference type="MIM" id="603027">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00757"/>
<dbReference type="OpenTargets" id="ENSG00000130957"/>
<dbReference type="PharmGKB" id="PA28019"/>
<dbReference type="eggNOG" id="KOG1458">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0158">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000015513"/>
<dbReference type="HOGENOM" id="HOG000191265"/>
<dbReference type="HOVERGEN" id="HBG005627"/>
<dbReference type="InParanoid" id="O00757"/>
<dbReference type="KO" id="K03841"/>
<dbReference type="OMA" id="MSDRSPF"/>
<dbReference type="OrthoDB" id="EOG091G0AZP"/>
<dbReference type="PhylomeDB" id="O00757"/>
<dbReference type="TreeFam" id="TF314824"/>
<dbReference type="BioCyc" id="MetaCyc:HS05462-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-70263">
<property type="pathway name" value="Gluconeogenesis"/>
</dbReference>
<dbReference type="SABIO-RK" id="O00757"/>
<dbReference type="UniPathway" id="UPA00138"/>
<dbReference type="EvolutionaryTrace" id="O00757"/>
<dbReference type="GenomeRNAi" id="8789"/>
<dbReference type="PRO" id="PR:O00757"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130957"/>
<dbReference type="CleanEx" id="HS_FBP2"/>
<dbReference type="Genevisible" id="O00757">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030018">
<property type="term" value="C:Z disc"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0042132">
<property type="term" value="F:fructose 1,6-bisphosphate 1-phosphatase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030388">
<property type="term" value="P:fructose 1,6-bisphosphate metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006002">
<property type="term" value="P:fructose 6-phosphate metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006000">
<property type="term" value="P:fructose metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005986">
<property type="term" value="P:sucrose biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd00354">
<property type="entry name" value="FBPase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_01855">
<property type="entry name" value="FBPase_class1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000146">
<property type="entry name" value="FBPase_class-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR033391">
<property type="entry name" value="FBPase_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR028343">
<property type="entry name" value="FBPtase"/>
</dbReference>
<dbReference type="InterPro" id="IPR020548">
<property type="entry name" value="Fructose_bisphosphatase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11556">
<property type="entry name" value="PTHR11556"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00316">
<property type="entry name" value="FBPase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF500210">
<property type="entry name" value="FBPtase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000904">
<property type="entry name" value="FBPtase_SBPase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00115">
<property type="entry name" value="F16BPHPHTASE"/>
</dbReference>
<dbReference type="PROSITE" id="PS00124">
<property type="entry name" value="FBPASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0021">Allosteric enzyme</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0119">Carbohydrate metabolism</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0312">Gluconeogenesis</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Fructose-1,6-bisphosphatase isozyme 2" id="PRO_0000200504">
<location>
<begin position="1"/>
<end position="339"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP" evidence="13">
<location>
<begin position="28"/>
<end position="32"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="AMP" evidence="13">
<location>
<begin position="113"/>
<end position="114"/>
</location>
</feature>
<feature type="region of interest" description="Important for interaction with ALDOA" evidence="11">
<location>
<begin position="3"/>
<end position="10"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="213"/>
<end position="216"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="245"/>
<end position="249"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="12">
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1">
<location>
<position position="69"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1">
<location>
<position position="98"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2">
<location>
<position position="98"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2">
<location>
<position position="119"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3">
<location>
<position position="119"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2; via carbonyl oxygen">
<location>
<position position="121"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3">
<location>
<position position="122"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 3">
<location>
<position position="281"/>
</location>
</feature>
<feature type="binding site" description="AMP; via carbonyl oxygen" evidence="13">
<location>
<position position="18"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="122"/>
</location>
</feature>
<feature type="binding site" description="AMP" evidence="13">
<location>
<position position="141"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="265"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="275"/>
</location>
</feature>
<feature type="site" description="Important for the conversion from active R-state to inactive T-state in the presence of AMP">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="216"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs573212." id="VAR_024448" evidence="8 15">
<original>V</original>
<variation>L</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduces sensitivity to inhibition by AMP and Ca(2+) and activation by Mg(2+). Decreases binding to ALDOA." evidence="11">
<location>
<begin position="1"/>
<end position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduces sensitivity to inhibition by AMP and Ca(2+) and activation by Mg(2+). Decreases binding to ALDOA.">
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces sensitivity to inhibition by AMP and Ca(2+) and activation by Mg(2+). Decreases binding to ALDOA.">
<location>
<begin position="1"/>
<end position="6"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces sensitivity to inhibition by AMP and Ca(2+) and activation by Mg(2+). Decreases binding to ALDOA.">
<location>
<begin position="1"/>
<end position="5"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces sensitivity to inhibition by AMP and Ca(2+) and activation by Mg(2+). Decreases binding to ALDOA.">
<location>
<begin position="1"/>
<end position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinetic properties but decreases binding to ALDOA.">
<location>
<begin position="1"/>
<end position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinetic properties and interaction with ALDOA.">
<location>
<begin position="1"/>
<end position="2"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinetic properties and interaction with ALDOA.">
<location>
<position position="1"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces sensitivity to AMP; when associated with M-178 and C-180." evidence="9">
<original>K</original>
<variation>E</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Causes conformational change of N-terminal residues and decreased sensitivity towards AMP with lack of conversion to the inactive T-state in the presence of AMP.">
<original>Q</original>
<variation>R</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduces affinity towards Ca(2+) and slightly reduces affinity towards Mg(2+)." evidence="10">
<original>E</original>
<variation>Q</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces sensitivity to AMP; when associated with E-21 and C-180." evidence="9">
<original>T</original>
<variation>M</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces sensitivity to AMP; when associated with E-21 and M-178." evidence="9">
<original>Q</original>
<variation>C</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost completely abolishes nuclear localization." evidence="12">
<original>KKKGK</original>
<variation>AAAGA</variation>
<variation>EEEGE</variation>
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Minor reduction in nuclear localization.">
<original>K</original>
<variation>E</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Minor reduction in nuclear localization.">
<original>K</original>
<variation>E</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduces nuclear lozalization.">
<original>K</original>
<variation>E</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly reduces nuclear localization.">
<original>K</original>
<variation>E</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="14"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="30"/>
<end position="50"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="58"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="74"/>
<end position="87"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="92"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="111"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="127"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="133"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="161"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="182"/>
<end position="188"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="189"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="193"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="208"/>
<end position="211"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="214"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="222"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="235"/>
<end position="237"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="249"/>
<end position="259"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="262"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="268"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="282"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="299"/>
<end position="302"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="317"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="322"/>
<end position="335"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HE0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HE2"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ET5"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ET6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z1N1"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12507293"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16213487"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17350621"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18214967"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19626708"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22120740"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24086250"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9678974"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<evidence key="17" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22120740"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24086250"/>
</source>
</evidence>
<sequence length="339" mass="36743" checksum="196B06D744710BC4" modified="2005-09-27" version="2">
MTDRSPFETDMLTLTRYVMEKGRQAKGTGELTQLLNSMLTAIKAISSAVRKAGLAHLYGI
AGSVNVTGDEVKKLDVLSNSLVINMVQSSYSTCVLVSEENKDAIITAKEKRGKYVVCFDP
LDGSSNIDCLASIGTIFAIYRKTSEDEPSEKDALQCGRNIVAAGYALYGSATLVALSTGQ
GVDLFMLDPALGEFVLVEKDVKIKKKGKIYSLNEGYAKYFDAATTEYVQKKKFPEDGSAP
YGARYVGSMVADVHRTLVYGGIFLYPANQKSPKGKLRLLYECNPVAYIIEQAGGLATTGT
QPVLDVKPEAIHQRVPLILGSPEDVQEYLTCVQKNQAGS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>